Target intelligence / Profile preview

Gastroesophageal junction acid pocket (Acid pocket)

Target
Acid pocket
Molecular classification
Other
01

Overview

The gastroesophageal junction (GEJ) acid pocket is a physiological phenomenon characterized by a layer of unbuffered, highly acidic gastric juice (pH 1.0–2.0) that forms in the proximal stomach following a meal (Fletcher et al., 2001, Gastroenterology). While the bulk of the meal buffers the rest of the stomach, this pocket remains unbuffered and sits near the GEJ, serving as the primary reservoir for acid reflux into the esophagus (Kahrilas et al., 2013, American Journal of Gastroenterology). In patients with gastroesophageal reflux disease (GERD), the acid pocket is often larger or more frequently positioned above the diaphragm, especially in the presence of a hiatal hernia (Beaumont et al., 2010, Gut). Therapeutic intervention focuses on neutralizing this acidity or physically displacing the pocket to prevent mucosal damage. Alginate-based therapies are particularly effective as they form a neutral-pH raft that floats atop the gastric contents, while proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) reduce the overall production of the acid that constitutes the pocket (Rohof et al., 2013, Clinical Gastroenterology and Hepatology).

Other names
Postprandial acid pocketGastric acid pocketProximal gastric acid pocket
02

Mechanism of action

Drugs target the acid pocket through physical displacement, neutralization, or secretion inhibition. Alginates react with gastric acid to form a neutral-pH raft that floats on top of the stomach contents, physically displacing the acid pocket away from the gastroesophageal junction or acting as a mechanical barrier to reflux (Rohof et al., 2013, Clinical Gastroenterology and Hepatology). Proton pump inhibitors (PPIs) and potassium-competitive acid blockers (P-CABs) reduce the volume and acidity of the pocket by inhibiting the H+/K+-ATPase pump in parietal cells (Kahrilas et al., 2013, American Journal of Gastroenterology).

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Sodium overload (associated with alginate formulations)Rebound acid hypersecretion upon discontinuation of PPIsNutrient malabsorption (e.g., Vitamin B12, Magnesium) with chronic acid suppressionIncreased risk of enteric infections such as Clostridioides difficile
06

Interacting drugs

Sodium alginate

6 more in the full profile.

07

Biomarkers

Postprandial gastric pHGastroesophageal junction pH-metryHigh-resolution manometry (HRM) with impedance

Beyond the preview

Go deeper on Gastroesophageal junction acid pocket (Acid pocket).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastroesophageal junction acid pocket (Acid pocket).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call